North America Biochip Market Growth, Trends and Forecasts (2016-2021)

North America Biochip Market Growth, Trends and Forecasts (2016-2021)

Purchase Report

A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput and speed. Typically, a biochip's surface area is no larger than a fingernail. Like a computer chip that can perform millions of mathematical operations in one second, a biochip can perform thousands of biological reactions, such as decoding genes, in a few seconds.

The North American biochip market was valued as a USD 6.30 billion in 2016. It is expected to become a USD 19.41 billion by 2021 thereby growing at a CAGR as high as 32.39%. This is a market to watch out for its great potential.

The biochip is basically segmented into three categories namely on the basis of products, applications and finally geography. The major factors which contributed to the growth of this market are increased application in cancer research, growth in personalized medicine and increased commercial application of biochips. The challenges faced by this market are low commercial acceptability due to higher costs, standardization issues and availability of alternate technologies.

From the geographical point of view, North America has the major chunk of the market share. In North America, USA market is the biggest. Following North America is Europe which has the next major market share. Biochip market has started recently in the emerging nations which have become an area where major investment is expected to happen which in turn helps in the growth of this market. In the APAC sector China and South Korea have been identified as potential emerging markets due to high R&D investments in the medical fields in recent times.

The major players in this biochip markets are Abbott Laboratories, Affymetrix,Inc , Agilent Technologies, Beckman Coulter, Biomeriuex, Biorad Laboratories, Roche Diagnostics, PerkinElmer and GE Healthcare.

1. INTRODUCTION

1.1 Report Description

1.2 Research Methodology

1.3 Stakeholders

  2. EXECUTIVE SUMMARY

2.1 Key Findings

2.2 Market Overview

  3. MARKET OVERVIEW

3.1 Market Defenition

3.1.1 Introduction

3.2 Market Segmentation

3.2.1 Products

3.2.2 Application

3.2.3 Geography

3.3 Market Drivers

3.3.1 Increasing application of Proteomics & Genomics in Cancer Research

3.3.2 Growth in personalized medicine

3.3.3 Regulatory approval for personalized medicine

3.3.4 Increased commercial application of Biochips

3.4 Market Limitations

3.4.1 Standardization

3.4.2 Low commercial acceptability due to the high costs

3.4.3 Availability of alternate technologies

3.4.5 Limites skilled population in the biochip market

  4. NORTH AMERICA MARKETS : SEGMENTATION BY PRODUCT

4.1 DNA Microarrays

4.2 Lab on a chip/ Microfuidics

4.3 Protein Microarrays

4.4 Tissue Biochips

4.5 Carbohydrate Biochips

  5. NORTH AMERICA MARKETS : SEGMENTATION BY APPLICATION

5.1 Gene Sequencing

5.2 Gene Expression

5.3 Cancer Research

5.4 Proteomics

5.5 Drug Discovery

5.6 Clinical Diagnosis

5.7 Genomics

5.8 Toxicogenomics

  6. NORTH AMERICAN MARKETS: SEGMENTATION BY GEOGRAPHY

6.1 USA

6.2 Canada

6.3 Mexico

  7. COMPETITIVE LANDSCAPE

7.1 Introduction

7.2 Mergers & Acquisitions

7.3 Expansions

7.4 New Product Launch

7.5 Collaborations

  8. COMPANY PROFILES

Abbott Laboratories

Affymetrix Inc

Agilent Technologies

Beckman Coulter Inc

Bio-Rad Laboratories Inc

Illumina Corporated

Life Technologies Corp

Perkinelmer

GE Healthcare

 

Purchase Report

Our Clients Include View All

Looking to Customize Report?

Complete your payment details below

Shipping & Billing Information

Payment Information